Bucks County, PA Congressman Michael Fitzpatrick (R-Pa.) has spoken out about the controversies surrounding permanent contraceptive device Essure, saying the manufacturer severely underestimated its harmful effects and may have concealed the true risks of the device (which include pain, abdominal injuries, heavy bleeding and fetal death) and downplayed the number of adverse event reports it received—allegations he has been urging the FDA to look into since February 2016. He notes that while the FDA cited only five fetal deaths associated with Essure, an independent report cites over 300.
Essure, marketed as a permanent contraceptive device to be 99% effective, was first approved by the FDA in 2002. However, the device has recently been associated with thousands of complaints made women who experienced severe adverse side-effects from Essure, including pregnancy, ectopic pregnancy, miscarriage, perforation of the uterus or other organs, migration of the device, and other complications. If you or a loved one experienced complications after being implanted with Essure, call us at 888-984-7988 to speak confidentially with an attorney about your potential claim.